Delivery Order SPE2DB22D1202-SPE2DB24FVDJ7
Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $5,760.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 4 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of November 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This federal contract award, valued at $2,715.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 milligram Glimepiride tablets, a medication used to treat type 2 diabetes, with an ultimate completion date of January 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,529.84 fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,281.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Glimepiride 2 mg tablets, a medication used to treat type 2 diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,979.81 firm fixed-price delivery order covers the procurement of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2020. This award is associated with Amerisourcebergen's $999,999,999 Indefinite...
- This federal contract award, valued at $8,413.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of November 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,456.72 firm fixed-price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,960.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used in the management of diabetes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,386.08 firm-fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,546.94 Firm Fixed Price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of May 23, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...